Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30
Strategic Growth and Market Potential Drive Buy Rating for MediWound Despite Revenue Decline
Urban Outfitters To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Wednesday
MediWound Analyst Ratings
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $25
MediWound Ltd. Advances Development With EscharEx IND Submission Planned for Year-End and NexoBrid FDA Pediatric Approval
TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25
MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript
Express News | Mediwound Shares Fall 4.8% Premarket After Q3 Results
MediWound Advances With FDA Approval and New Funding
MediWound GAAP EPS of -$0.98 Misses by $0.53, Revenue of $4.35M Misses by $1.66M
MediWound | 6-K: Report of foreign private issuer (related to financial reporting)
Earnings Flash (MDWD) MEDIWOUND Posts Q3 Revenue $4.4M, Vs. Street Est of $6.0M
Express News | Mediwound : Anticipates $20 Mln in Total Revenue for 2024
Express News | Mediwound Q3 Gross Profit USD 700 Thousand
MediWound 3Q Loss $26.3M >MDWD
MediWound 3Q Loss/Shr 98c >MDWD
Earnings Scheduled For November 26, 2024
MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
Here's the Major Earnings Before the Open Tomorrow